DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
DRNA
Delisted
DRNA was delisted on the 27th of December, 2021.
55 hedge funds and large institutions have $79.7M invested in Dicerna Pharmaceuticals, Inc. in 2016 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 19 increasing their positions, 17 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
55
Holders Change
-3
Holders Change %
-5.17%
% of All Funds
1.47%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
4
Increased
19
Reduced
17
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Bank of Montreal
Toronto,
Ontario, Canada
| $13K | +$12K | +2,186 | +1,145% |
|
52
Bank of America
Charlotte,
North Carolina
| $11K | -$10.7K | -1,870 | -49% |
|
|
TRCT
53
Tower Research Capital (TRC)
New York
| $7K | -$16.7K | -2,935 | -70% |
|
54
BlackRock
New York
| $1K | +$1K | +216 | New |
|
55
Geode Capital Management
Boston,
Massachusetts
| $544 | +$7 | +1,371 | +1% |
|
|
PP
56
PDT Partners
New York
| – | -$235K | -19,833 | Closed |
|
|
CS
57
Credit Suisse
Zurich,
Switzerland
| – | -$189K | -15,886 | Closed |
|
|
MLICM
58
Metropolitan Life Insurance Company (MetLife)
New York
| – | -$141K | -11,866 | Closed |
|
|
PAM
59
Panagora Asset Management
Boston,
Massachusetts
| – | -$81K | -6,819 | Closed |
|
60
BNP Paribas Financial Markets
Paris,
France
| – | -$37.5K | -3,156 | Closed |
|
61
UBS Group
Zurich,
Switzerland
| – | -$3K | -242 | Closed |
|